Literature DB >> 15816004

A strategy for high-resolution protein identification in surface-enhanced laser desorption/ionization mass spectrometry: calgranulin A and chaperonin 10 as protein markers for endometrial carcinoma.

Jingzhong Guo1, Eric C C Yang, Leroi Desouza, Georg Diehl, Mary Joe Rodrigues, Alexander D Romaschin, Terence J Colgan, K W Michael Siu.   

Abstract

Surface-enhanced laser desorption/ionization-mass spectrometry (SELDI-MS) has conventionally been practiced on linear time of flight (TOF) which has low mass accuracy and resolution. Here we demonstrate in an examination of both malignant and nonmalignant endometrial tissue homogenates that high mass accuracy and resolution in the MS stage are crucial. Using a commercially available quadrupole/TOF (QqTOF), we were able to resolve two potential cancer markers, subsequently identified off-line as chaperonin 10 and calgranulin A, that differ by 8 Da in mass. Two off-line protein identification protocols were developed: the first was based on size-exclusion chromatography (SEC), sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), protein extraction, trypsin digestion, and matrix-assisted laser desorption/ionization-tandem MS (MALDI-MS/MS); the second on SEC and shotgun nano-liquid chromatography (nanoLC)-MS/MS. Analyses on a cohort of 44 endometrial homogenates showed 22 out of 23 nonmalignant samples had nondetectable to very low abundance of chaperonin 10 and calgranulin A; 17 of the 21 malignant samples had detectable to abundant levels of both proteins. Immunohistochemical staining of a tissue microarray of 32 samples showed that approximately half of malignant endometrial tissues exhibited positive staining for calgranulin A in the malignant epithelium, while 9 out of 10 benign tissues exhibited negative epithelial staining. In addition, macrophages/granulocytes in malignant as well as nonmalignant tissues showed positive staining. No immunostaining occurred in stroma or myometrium. Calgranulin A, in combination with chaperonin 10 and other proteins, may eventually constitute a panel of markers to permit diagnosis and screening of endometrial cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15816004     DOI: 10.1002/pmic.200401059

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  4 in total

1.  Identification of potential serum markers for endometrial cancer using protein expression profiling.

Authors:  Masashi Takano; Yoshihiro Kikuchi; Takayoshi Asakawa; Tomoko Goto; Tsunekazu Kita; Kazuya Kudoh; Junzo Kigawa; Noriaki Sakuragi; Masaru Sakamoto; Toru Sugiyama; Nobuo Yaegashi; Hiroshi Tsuda; Hiroshi Seto; Mieko Shiwa
Journal:  J Cancer Res Clin Oncol       Date:  2009-09-16       Impact factor: 4.553

Review 2.  Contributions of advanced proteomics technologies to cancer diagnosis.

Authors:  Sergio Ciordia; Vivian de Los Ríos; Juan-Pablo Albar
Journal:  Clin Transl Oncol       Date:  2006-08       Impact factor: 3.405

3.  Mass spectroscopic characteristics of low molecular weight proteins extracted from calcium oxalate stones: preliminary study.

Authors:  Wen-Chi Chen; Chien-Chen Lai; Chein-Cheng Lai; Yuhsin Tsai; Yu-Hsin Tsai; Wei-Yong Lin; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

Review 4.  Proteomic Biomarkers for the Detection of Endometrial Cancer.

Authors:  Kelechi Njoku; Davide Chiasserini; Anthony D Whetton; Emma J Crosbie
Journal:  Cancers (Basel)       Date:  2019-10-16       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.